We're sorry but this app doesn't work properly without JavaScript enabled. Please enable it to continue. Liontrust GF High Yield Bond Fund Update - Q2 2025 - MeDirect Bank Malta

Picture your Future. Save for it by earning 1.5% on a 1-year Term Deposit Account! Learn more.

Liontrust GF High Yield Bond Fund Update – Q2 2025

Liontrust GF High Yield Bond Fund is manufactured by Liontrust Fund Partners LLP and represented in Malta by MeDirect Bank (Malta) plc.

The Fund (C5 sterling accumulation class) returned 3.2%* in sterling terms in Q1 2025 while the ICE Bank of America Merrill Lynch Global High Yield Index (GBP hedged) comparator benchmark returned 3.1% and the average return for the IA Sterling High Yield reference sector was 2.3%. The primary B5 US dollar share class returned 3.3%, while the ICE Bank of America Merrill Lynch Global High Yield Index (USD hedged) comparator benchmark returned 3.1% and the average return for the EAA Fund USD High Yield Bond (Morningstar) reference sector was 3.8%.

We also compare the Fund’s performance to a leading Global High Yield ETF (seeking to outperform by 1.5% a year) †. The Fund’s C5 sterling shares class return was slightly ahead of the ETF in Q2 and has now outperformed by eight percentage points since inception (June 2018).

The global high yield market returned 3.12% (US dollar terms) in the second quarter of 2025. The US high yield market produced a 3.57% return. In Europe, the high yield market returned 2.67%. BBs were best performing part of the market by rating at 3.14%, only marginally ahead of single Bs at 3.12%, and 2.81% return for CCCs. 

During the quarter there were two notable positive credit stories amongst out holdings. Worldpay, a payment tech business is being acquired by an investment grade rated company called Global Payments. As it is a strong conviction trade, we hold a concentrated position within the fund and benefited from a three- point pop in bond price on the back of this news. We’ve chosen to hold the position rather than take profit as we are being paid an attractive coupon and will reassess as we get closer to the closing date of the transaction.  

The other positive credit story is related to Chart Industries, a global manufacturer of engineered equipment servicing multiple market applications in energy and industrial gas. As the business is more on the cyclical side we hold a modest position in the Fund. The investment grade rated company, Flowserve announced an agreement to merge with Chart Industries, in a deal which is expected to close at the end of the year. The combination would address an entire life cycle for customers, from design through to aftermarket support. The latter has grown in recent years, offering sticky customer relationships and higher margins; the rating agencies have taken the news positively and bond ratings have been put on positive outlook.

We participated in a handful of new issues in both the US and European markets across the BB and B space.  Amongst the new credits added to the portfolio, we invested in QXO building products, Wolseley, Currenta Group and Urbaser. The rest of the credits were companies we were already familiar with or currently own in the portfolio (hence, already comforted by the company fundamentals.  

The rest of the activity in the quarter was centred around investing cash from fund inflows across existing holdings, ideas from our watchlist and also in bonds that had been beaten up (disproportionally, in our view) post-tariff related headlines. Our focus on idiosyncratic risk and the stock-picking choices we made all contributed to our positive performance this quarter.  

It is also worth noting the growth in the Fund during the period, with assets now above $200m. 

Outlook

At the start of the quarter we saw a shake-up in spreads offered in the high yield market on the back of Trump tariff headlines and speculation. We saw sectors, predominantly cyclical ones like autos, take a hit as the market was worried about the level of tariffs and the domino effect it would have across the supply chain, right through to the end product. There were some sectors impacted more than others, but we took advantage of what we deemed as some mis-pricing where bonds were sold down but fundamentals remained solid and spreads attractive, particularly in US dollar issues.

Since those turbulent few weeks, the market started to absorb the headlines and hope was restored that the tariffs wouldn’t be as bad as the market had originally thought. The global high yield market retraced its initial move down and is back to the tighter spreads we saw pre-liberation day. The next milestone in focus is the 90-day reciprocal tariff deadline on 9th July, this could potentially spark another round of volatility in the market, with the potential for a wider implication on global growth. The Fund has a good level of cash to take advantage of any investment opportunity that might present itself in a softer market. 

With the uncertain backdrop around markets over the last quarter, many investors have taken the flight to quality and invested in the higher quality parts of the high yield spectrum. This has benefitted our strategy as this is the part of the market we are already exposed to and continues to be our sweet spot.  

On the macro side, the market is thinking about the likelihood of a rate cut in the US by the end of the year. The focus has been on data releases which are currently indicating a more resilient economy than the market expected, giving less of a motive for the Fed to cut rates.  

Defaults in the high yield market remain low and below historical averages; we’ve seen a few isolated cases of distressed exchanges and restructuring. The level of defaults is increasing (skewed by select companies) but at a very modest pace, broadly indicating that high yield company balance sheets are in good shape and have been resilient facing current headwinds. The primary market has been open but fairly quiet till the latter part of the quarter. In recent weeks, primary issuance has ramped up across BB and B rating categories – most of the deals have been to refinance existing debt but we have come across a handful of deals including the funding of shareholder distributions, which is fairly aggressive. The deals were successfully done, at relative tight spreads not offering much of a new issue premium in some cases. This demonstrates how the demand for high yield bonds is strong, how companies are taking advantage of issuing bonds at favourable levels and how the high yield market overall is well supported by this positive technical. It is external ‘noise’ that is likely to be the cause of short-term spread widening. 

We take a longer-term view in investments in our portfolio and therefore are invested in companies that we believe can withstand bouts of market volatility and achieve a good level of return. We run a concentrated portfolio, where our position size reflects our level of conviction, we are index agnostic and our process means we are primarily invested in higher quality credits. The yield offered on the fund is 7.1%, which we believe is highly attractive from a risk/reward standpoint.  


Liontrust Key risks & Disclaimers:

Past performance is not a guide to future performance. Do remember that the value of an investment and the income generated from them can fall as well as rise and is not guaranteed, therefore, you may not get back the amount originally invested and potentially risk total loss of capital.

The issue of units/shares in Liontrust Funds may be subject to an initial charge, which will have an impact on the realisable value of the investment, particularly in the short term. Investments should always be considered as long term.

Investment in the GF High Yield Bond Fund involves foreign currencies and may be subject to fluctuations in value due to movements in exchange rates. The value of fixed income securities will fall if the issuer is unable to repay its debt or has its credit rating reduced. Generally, the higher the perceived credit risk of the issuer, the higher the rate of interest. Bond markets may be subject to reduced liquidity. The Fund may invest in emerging markets/soft currencies and in financial derivative instruments, both of which may have the effect of increasing volatility. The Fund may invest in derivatives. The use of derivatives may create leverage or gearing. A relatively small movement in the value of a derivative’s underlying investment may have a larger impact, positive or negative, on the value of a fund than if the underlying investment was held instead.

Issued by Liontrust Fund Partners LLP (2 Savoy Court, London WC2R 0EZ), authorised and regulated in the UK by the Financial Conduct Authority (FRN 518165) to undertake regulated investment business.

This document should not be construed as advice for investment in any product or security mentioned, an offer to buy or sell units/shares of Funds mentioned, or a solicitation to purchase securities in any company or investment product. Examples of stocks are provided for general information only to demonstrate our investment philosophy. It contains information and analysis that is believed to be accurate at the time of publication, but is subject to change without notice. Whilst care has been taken in compiling the content of this document, no representation or warranty, express or implied, is made by Liontrust as to its accuracy or completeness, including for external sources (which may have been used) which have not been verified. It should not be copied, faxed, reproduced, divulged or distributed, in whole or in part, without the express written consent of Liontrust. Always research your own investments and (if you are not a professional or a financial adviser) consult suitability with a regulated financial adviser before investing.


MeDirect Disclaimers:

This information has been accurately reproduced, as received from Liontrust Fund Partners LLP. No information has been omitted which would render the reproduced information inaccurate or misleading. This information is being distributed by MeDirect Bank (Malta) plc to its customers. The information contained in this document is for general information purposes only and is not intended to provide legal or other professional advice nor does it commit MeDirect Bank (Malta) plc to any obligation whatsoever. The information available in this document is not intended to be a suggestion, recommendation or solicitation to buy, hold or sell, any securities and is not guaranteed as to accuracy or completeness.

The financial instrument discussed in the document is intended for retail clients however, it may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.

If you invest in this product you may lose some or all of the money you invest. The value of your investment may go down as well as up. A commission or sales fee may be charged at the time of the initial purchase for an investment. Any income you get from this investment may go down as well as up. This product may be affected by changes in currency exchange rate movements thereby affecting your investment return therefrom. The performance figures quoted refer to the past and past performance is not a guarantee of future performance or a reliable guide to future performance. Any decision to invest should always be based upon the details contained in the Prospectus and Key Information Document (KID), which may be obtained from MeDirect Bank (Malta) plc.

Join MeDirect today to access the tools you need to put your money to work on your own terms.

Latest news articles

Experience better Banking

The sooner you start managing your money, your way, using the best-in-class tools, the sooner you’ll see results. 


Sign up and open your account for free, within minutes.

MeDirect_Multi-Devices-cards

You are leaving medirect.com.mt

Please be aware that the external site policies, or those of another MeDirect website, may differ from this website’s terms and conditions and privacy policy. The next website will open in a new browser window or tab.

 

Note: MeDirect is not responsible for any content on third party sites, nor does a link suggest endorsement of those sites and/or their content.

Login

We strive to ensure a streamlined account opening process, via a structured and clear set of requirements and personalised assistance during the initial communication stages. If you are interested in opening a corporate account with MeDirect, please complete an Account Opening Information Questionnaire and send it to corporate@medirect.com.mt.

For a comprehensive list of documentation required to open a corporate account please contact us by email at corporate@medirect.com.mt or by phone on (+356) 2557 4444.